Thyrocare Technologies Limited (THYROCARE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.238x

Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has a cash flow conversion efficiency ratio of 0.238x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.27 Billion ≈ $13.75 Million USD) by net assets (Rs5.34 Billion ≈ $57.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Thyrocare Technologies Limited financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Thyrocare Technologies Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Thyrocare Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see market cap of Thyrocare Technologies Limited for the company's overall valuation and market capitalisation.

Thyrocare Technologies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Thyrocare Technologies Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Procter & Gamble Health Limited NSE:PGHL	0.278x
Inwido AB ST:INWI	-0.029x
Puuilo Oyj HE:PUUILO	0.214x
Community Trust Bancorp Inc NASDAQ:CTBI	0.017x
SUPERLOOP LTD F:9SL	N/A
SKAN Group AG SW:SKAN	0.312x
HJ ShipBuilding & Construction Co Ltd KO:097230	0.112x
Vor Biopharma Inc NASDAQ:VOR	0.254x

Annual Cash Flow Conversion Efficiency for Thyrocare Technologies Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Thyrocare Technologies Limited from 2011 to 2026. View THYROCARE stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs5.86 Billion ≈ $63.38 Million	Rs2.16 Billion ≈ $23.39 Million	0.369x	+5.54%
2025-03-31	Rs5.47 Billion ≈ $59.16 Million	Rs1.91 Billion ≈ $20.69 Million	0.350x	+10.08%
2024-03-31	Rs5.28 Billion ≈ $57.06 Million	Rs1.68 Billion ≈ $18.13 Million	0.318x	+31.50%
2023-03-31	Rs5.35 Billion ≈ $57.88 Million	Rs1.29 Billion ≈ $13.98 Million	0.242x	+12.18%
2022-03-31	Rs5.27 Billion ≈ $56.95 Million	Rs1.13 Billion ≈ $12.26 Million	0.215x	-20.69%
2021-03-31	Rs4.27 Billion ≈ $46.21 Million	Rs1.16 Billion ≈ $12.55 Million	0.272x	-40.60%
2020-03-31	Rs3.67 Billion ≈ $39.65 Million	Rs1.68 Billion ≈ $18.13 Million	0.457x	+98.31%
2019-03-31	Rs4.35 Billion ≈ $47.06 Million	Rs1.00 Billion ≈ $10.85 Million	0.231x	-4.52%
2018-03-31	Rs4.43 Billion ≈ $47.94 Million	Rs1.07 Billion ≈ $11.57 Million	0.241x	+9.81%
2017-03-31	Rs4.07 Billion ≈ $43.99 Million	Rs894.44 Million ≈ $9.67 Million	0.220x	+18.57%
2016-03-31	Rs3.66 Billion ≈ $39.54 Million	Rs678.01 Million ≈ $7.33 Million	0.185x	+67.15%
2015-03-31	Rs3.11 Billion ≈ $33.60 Million	Rs344.68 Million ≈ $3.73 Million	0.111x	-50.51%
2014-03-31	Rs2.06 Billion ≈ $22.31 Million	Rs462.39 Million ≈ $5.00 Million	0.224x	-21.84%
2013-03-31	Rs1.60 Billion ≈ $17.31 Million	Rs459.23 Million ≈ $4.97 Million	0.287x	-28.11%
2012-03-31	Rs1.02 Billion ≈ $11.08 Million	Rs408.87 Million ≈ $4.42 Million	0.399x	-16.85%
2011-03-31	Rs675.33 Million ≈ $7.30 Million	Rs324.07 Million ≈ $3.50 Million	0.480x	--

About Thyrocare Technologies Limited

NSE:THYROCARE India Diagnostics & Research

Market Cap

$1.07 Billion

Rs99.01 Billion INR

Market Cap Rank

#8638 Global

#434 in India

Share Price

Rs622.10

Change (1 day)

+3.12%

52-Week Range

Rs349.55 - Rs1591.90

All Time High

Rs1591.90